OTCMKTS:SHTDY

Sinopharm Group Stock Forecast, Price & News

$14.02
+0.76 (+5.73 %)
(As of 04/15/2021 03:59 PM ET)
Add
Compare
Today's Range
$13.99
Now: $14.02
$14.20
50-Day Range
$11.25
MA: $11.94
$13.26
52-Week Range
$10.20
Now: $14.02
$14.35
Volume37,978 shs
Average Volume50,546 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and healthcare products in the People's Republic of China. Its Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail drug stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The company's Retail Pharmacy segment operates and franchises a network of retail drug stores. As of December 31, 2019, this segment had 5,021 retail pharmacies. Its Medical Devices segment distributes medical devices. The company's Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology development and medicine consultation, investment, goods and technology import and export, business consultation, health consultation, medical consultation, market information consultation and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities, as well as offers cleaning and sterilization services for medical instruments and devices. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China.

Industry, Sector and Symbol

Industry Medical Distribution
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:SHTDY
CUSIPN/A
CIKN/A
Phone86 21 2305 2666
Employees93,764
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

Headlines

UAE offers third shot of Chinese vaccine in some cases
March 17, 2021 |  finance.yahoo.com
Covid-19 Vaccines and How They Work
January 27, 2021 |  wsj.com
Chinese, UK COVID vaccines show promise
December 31, 2020 |  msn.com
See More Headlines

MarketRank

Overall MarketRank

0.60 out of 5 stars

Medical Sector

1373rd out of 2,020 stocks

Medical Distribution Industry

1st out of 4 stocks

Analyst Opinion: 0.0Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$14.02
+0.76 (+5.73 %)
(As of 04/15/2021 03:59 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SHTDY News and Ratings via Email

Sign-up to receive the latest news and ratings for SHTDY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Sinopharm Group (OTCMKTS:SHTDY) Frequently Asked Questions

What stocks does MarketBeat like better than Sinopharm Group?

Wall Street analysts have given Sinopharm Group a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Sinopharm Group wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are Sinopharm Group's key executives?

Sinopharm Group's management team includes the following people:
  • Mr. Qingming Yu, Exec. Chairman (Age 57)
  • Mr. Yong Liu, Pres & Exec. Director (Age 52)
  • Mr. Xiuchang Jiang, CFO & VP (Age 57)
  • Dr. Wei Liu, Joint Company Sec. (Age 63)
  • Mr. Yijian Wu, Joint Company Sec. (Age 51)
  • Mr. Wanyong Lian, VP (Age 50)
  • Mr. Shuangjun Xu, Non-Exec. VP (Age 52)
  • Mr. Wanjun Ma, VP (Age 52)
  • Mr. Dongjiu Li, VP (Age 56)
  • Mr. Maisong Cai, VP (Age 51)

Who are some of Sinopharm Group's key competitors?

What is Sinopharm Group's stock symbol?

Sinopharm Group trades on the OTCMKTS under the ticker symbol "SHTDY."

How do I buy shares of Sinopharm Group?

Shares of SHTDY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sinopharm Group's stock price today?

One share of SHTDY stock can currently be purchased for approximately $14.02.

How many employees does Sinopharm Group have?

Sinopharm Group employs 93,764 workers across the globe.

What is Sinopharm Group's official website?

The official website for Sinopharm Group is www.sinopharmgroup.com.cn.

How can I contact Sinopharm Group?

The company can be reached via phone at 86 21 2305 2666.


This page was last updated on 4/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.